Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00066066 · ClinicalTrials.gov registry record · Phase 2
Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers
A Phase 2 study, sponsored by The Forsyth Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 146
- Enrollment target
NCT00066066 is a Phase 2 study that has completed, run by The Forsyth Institute. The registered enrollment target is 146 participants.
The verdict
NCT00066066, a Phase 2 study, has completed, sponsored by The Forsyth Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 146 participants
- Enrollment target
Study Summary
The purpose of this study is to determine in current and non-smokers the clinical and microbiological effects of 3 therapies: scaling and root planing (SRP) alone; SRP in combination with the orally administered antibiotic metronidazole; and SRP with the orally administered antibiotics metronidazole and amoxicillin along with the locally delivered antibiotic doxycycline at periodontal pockets \>= 4 mm.
Interventions
- DRUG Amoxicillin
- DRUG Metronidazole
- DRUG Doxycycline
- PROCEDURE Scaling and root planing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2003-07 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00066066
The ClinicalTrials.gov registry entry for NCT00066066 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Forsyth Institute, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Amoxicillin is the first listed.
NCT00066066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00066066 about?
NCT00066066 is a clinical study titled "Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers". The purpose of this study is to determine in current and non-smokers the clinical and microbiological effects of 3 therapies: scaling and root planing (SRP) alone; SRP in combination with the orally administered antibiotic metronidazole; and SRP with the orally administered antibiotics metronidazole...
What is the current status of trial NCT00066066?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 146 participants. The study started on 2003-07. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00066066?
The interventions under investigation include: Amoxicillin (DRUG), Metronidazole (DRUG), Doxycycline (DRUG), Scaling and root planing (PROCEDURE).
Who is sponsoring clinical trial NCT00066066?
This trial is sponsored by The Forsyth Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.